In the treatment of advanced KIRC, commonly used drugs include tyrosine kinase inhibitors (TKIs) targeting the tumor cell growth pathway and vascular endothelial growth factor (VEGF) targeted therapies. The gene discussed is VEGFA; the disease is neoplasm.